Skip to main content
. 2022 Jan 13;12:805610. doi: 10.3389/fpls.2021.805610

TABLE 1.

Inhibition of the Wnt pathway with the biotransformation products.

graphic file with name fpls-12-805610-t001.jpg

Gray/white background highlights compounds with similar scaffold.

*The cell lines used were chosen to represent a broad variety of TNBC histotypes: luminal-like ductal (BT-20), squamous (HCC1806), and adenocarcinoma (MDA-MB-468); basal-like ductal (HCC1395) and adenocarcinoma (MDA-MB-231).

(a)Compounds are considered inactive and non-toxic if the highest concentration tested does not show a 20% reduction compared to the control.

(b)Compounds are considered “toxic” if the IC50 value against Renilla luciferase is less than 1.7-fold of the estimated TopFlash one (i.e., SI < 1.7), indicating that the decrease in observed signal in the TopFlash is due to or strongly affected by the toxic effect.